Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial Academic Article 2015 uri icon

authors

  • Arribas JR.
  • Podzamczer D.
  • PORTILLA SOGORB, JOAQUIN
  • Dronda F.
  • Iribarren JA.
  • Domingo P.
  • Pulido F.
  • Montero M.
  • Knobel H.
  • Cabié A.
  • Weiss L.
  • Girard PM.
  • Gatell JM.
  • OLE/RIS-EST13 Study Group
  • BOIX MARTINEZ, VICENTE
  • Landman R.
  • Pich J.
  • Mallolas J.
  • Martínez-Rebollar M.
  • Zamora FX.
  • Estrada V.
  • Crespo M.

publication date

  • 2015